Related Experiment Video
Updated: Mar 24, 2026
06:04
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
17.8K
Korean clinical practice guideline for benign prostatic hyperplasia.
Jeong Kyun Yeo1, Hun Choi2, Jae Hyun Bae2
1Department of Urology, Inje University College of Medicine, Busan, Korea.
Investigative and Clinical Urology
|March 12, 2016
Summary
This guideline offers evidence-based recommendations for diagnosing and treating benign prostatic hyperplasia (BPH) in men over 40. It synthesizes current research to aid primary care practitioners and urologists.
Area of Science:
- Urology
- Evidence-Based Medicine
- Clinical Practice Guidelines
Background:
- Benign Prostatic Hyperplasia (BPH) affects men over 40.
- There was a need for updated clinical practice guidelines for BPH in Korea.
Purpose of the Study:
- To develop a comprehensive Korean clinical practice guideline for the evaluation and treatment of Benign Prostatic Hyperplasia (BPH).
- To provide evidence-based recommendations for primary practitioners and urologists managing BPH.
Main Methods:
- Adaptation of existing international guidelines and de novo development.
- Comprehensive literature review (2009-2013) using medical search engines, including Korean data.
- Meta-analysis for key questions and recommendations, with evidence levels determined using Oxford Centre for Evidence-Based Medicine methods.
Main Results:
- A synthesized set of recommendations based on published evidence.
- Expert peer review and consensus meetings ensured guideline validity.
- The guideline addresses diagnosis and treatment for men over 40 with BPH.
Conclusions:
- The guideline provides a standardized approach to BPH management in Korea.
- It aims to improve the quality of care for men with BPH.
- This evidence-based guideline supports informed clinical decision-making for healthcare providers.
Related Concept Videos
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
945
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
945
01:20Disorders of the Male Reproductive System
5.4K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.4K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
595
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
595
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
710
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
710
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
393
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
393
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
633
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
633